ING, PALI and FNCH Among Pre-market Losers
Seeking AlphaApr 24 08:45 ET
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s
BenzingaApr 23 13:53 ET
KOPN, BTCM and CETX Among Mid-day Movers
Seeking AlphaApr 23 13:16 ET
Dow Jumps Over 200 Points; US Services PMI Falls In April
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 200 points on Tuesday.The Dow traded up 0.60% to 38,470.94 while the NASDAQ rose 1.44% to 15,673.22. The S&P 500
BenzingaApr 23 12:21 ET
Why Palisade Bio Stock Is Up Today
Palisade Bio, Inc. (NASDAQ:PALI) shares are trading higher Tuesday after the company entered into a collaboration with Strand Life Sciences.The Details:Palisade Bio said its collaboration with Strand
BenzingaApr 23 12:06 ET
Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience Among Healthcare Movers
Seeking AlphaApr 23 10:00 ET
Palisade Bio, Strand Life Sciences Team up on Colitis Drug Research
Seeking AlphaApr 23 09:28 ET
Express News | Palisade Bio Shares Rise 23% Premarket as Co Enters Into a Partnership With Strand Life Sciences
Moomoo 24/7Apr 23 09:10 ET
Express News | Palisade Bio Shares Are Trading Higher After the Company's Entered a Collaboration With Strand Life Sciences
Moomoo 24/7Apr 23 08:34 ET
Express News | Palisade Bio Enters Collaboration With Strand Life Sciences Aimed At Advance Precision Medicine Approach; Collaboration Provides Palisade Bio Access To Advanced Bioinformatics Tools
Moomoo 24/7Apr 23 08:33 ET
Express News | Palisade Bio Enters Into Strategic Collaboration With Strand Life Sciences to Advance Precision Medicine Approach
Moomoo 24/7Apr 23 08:30 ET
Palisade Bio Enters Into Strategic Collaboration With Strand Life Sciences to Advance Precision Medicine Approach
– Collaboration grants Palisade Bio access to cutting-edge expertise and tools in bioinformatics – Partnership marks a significant value-driving milestone in Palisade Bio's mission to redefine UC trea
Palisade BioApr 23 00:00 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Palisade Bio (PALI)
TipRanksApr 17 11:30 ET
Looking Into Palisade Bio's Recent Short Interest
Palisade Bio's (NYSE:PALI) short percent of float has risen 756.82% since its last report. The company recently reported that it has 27 thousand shares sold short, which is 3.77% of all regular shares
BenzingaApr 17 10:45 ET
Express News | Maxim Group Maintains Buy on Palisade Bio, Adjusts Price Target To $22.5 (Reverse Stock Split 1:15)
Moomoo 24/7Apr 16 13:27 ET
Palisade Bio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/16/2024 238.89% Maxim Group $22.5 → $22.5 Maintains Buy 11/17/2023 -77.41% Maxim Group → $1.5 Upgrades
BenzingaApr 16 13:22 ET
JAGX, BSGM and SXTC Among Mid-day Movers
Seeking AlphaApr 16 12:40 ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersPalisade Bio (NASDAQ:PALI) stock increased by 65.1% to $6.87 during Tuesday's regular session. The company's market cap stands at $5.8 million. China SXT Pharmaceuticals (NASDAQ:SXTC) shares ro
BenzingaApr 16 12:31 ET
Why Palisade Bio Stock Is Soaring Today
Palisade Bio, Inc. (NASDAQ:PALI) shares are trading higher Tuesday after the company announced the completion of its analysis evaluating ex-vivo bioactivation of PALI-2108.The Details:Palisade Bio sai
BenzingaApr 16 11:47 ET
Palisade Bio, Marinus Pharmaceuticals, Poseida Therapeutics Among Healthcare Movers
Seeking AlphaApr 16 10:00 ET
No Data
No Data